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Lymphoid  tissue  inducer  (LTi)  cells  are  re-
quired for the formation of lymph nodes dur-
ing embryogenesis (Mebius, 2003). LTi cells 
interact with stromal cells and, via production 
of the cytokines lymphotoxin  and TNF, in-
duce stromal cell production of chemokines and   
expression of the adhesion molecules ICAM1 and 
VCAM1 (Mebius, 2003). This, in turn, attracts 
and retains other lymphocytes, thereby initiating 
the formation of a lymph node primordium. In 
the mouse fetus, LTi cells express c-kit (CD117) 
and lymphotoxin  and  but lack CD3 and 
other lineage markers, and most of these cells 
express CD4 although CD4 LTi cells have 
also been described (Mebius et al., 1997, 2003; 
Yoshida et al., 1999). The human counter-
part of LTi was identified recently as lineage 
(Lin; CD3CD19CD14) CD127+RORC+ 
cells,  which  are  present  in  fetal  lymph  node   
anlagen (Cupedo et al., 2009). Functionally, 
these cells induce ICAM1 and VCAM1 on 
mesenchymal stem cells (MSCs) in a TNF- and 
LT-–dependent manner, supporting the no-
tion that they represent the human equivalent of 
mouse LTi cells.
Evidence suggests that LTi cells and conven-
tional NK (cNK) cells are developmentally re-
lated cell types. Mouse fetal CD3CD4+ LTi 
cells were shown to develop into NK1.1+ cells 
but not into T and B cells, suggesting that LTi 
cells are precursors of cNK cells (Mebius et al., 
1997). More recently, it was demonstrated that 
development of both LTi and cNK needs the 
Helix loop helix protein Id2 (Yokota et al., 1999; 
Eberl et al., 2004), whereas E12 and/or E47, 
which are encoded by the E2A locus, inhibit   
the generation of both LTi cells and cNK cells 
(Boos et al., 2007). However, differences exist in 
transcriptional control of development of these   
cells, as RORt (RORC in the human), a 
nuclear hormone receptor critical for develop-
ment of LTi cells, is not needed for cNK cell 
development (Satoh-Takayama et al., 2008). 
Furthermore, there are differences in cytokine 
requirements of LTi cells and cNK because 
LTi  cell  development  requires  the  gamma 
common  receptor  but  is  IL-15  independent 
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Lymphoid tissue inducer (LTi) cells are required for lymph node formation during fetal  
development, and recent evidence implies a role in mucosal immunity in the adult.  
LTi cells share some phenotypic features of conventional natural killer (NK; cNK) cells;  
however, little is known to date about the relationship between these two cell types. We 
show that lineage (Lin) CD127+RORC+ LTi-like cells in human tonsil are precursors to 
CD56+CD127+RORC+NKp46+ cells, which together comprise a stable RORC+ lineage. We find 
that LTi-like cells and their CD56+ progeny can be expanded and cloned ex vivo without loss 
of function and without conversion into cNK cells. Clonal analysis reveals heterogeneity of 
cytokine production within the CD127+ LTi-like population. Furthermore, we identify within 
the tonsil a cNK precursor population that is characterized as LinCD117+CD161+CD127 
cells. Overall, we propose that CD127+RORC+ cells, although they share some characteristics 
with cNK cells, represent a functionally and developmentally distinct lineage.
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negative for CD161. The CD127+ populations expressed 
CD117, which was not present on cNK cells, but were neg-
ative for CD34 (unpublished data). Furthermore, cNK cells 
expressed higher levels of NKp46 and NKG2D than the 
CD127+ populations. Tonsil LTi cells, but not cNK, also   
expressed CD25, the IL-2 receptor  chain, whereas the   
IL-15R chain on tonsil CD127+ LTi-like cells was expressed 
at levels equivalent to those on cNK cells (unpublished data). 
Our data show that the phenotype of CD56+CD127+ cells is 
very similar to that of NK22 cells, suggesting that these repre-
sent two highly overlapping if not identical cell types.
Recently, we found that fetal CD56 LTi-like cells de-
veloped into CD56+CD127+ cells after 2 wk of culture with 
IL-15. Although these data suggested a precursor progeny 
relationship of LTi and CD56+CD127+ cells, we could not 
exclude the possibility that the CD56+ cells were derived 
from a small number of highly proliferating CD56+ cells con-
taminating the starting CD56CD127+ population. To test 
whether tonsil CD56 LTi cells also develop into CD56+ 
cells and to exclude the possibility that the appearance of 
CD56+ cells in cultures with IL-15 is the result of outgrowth 
of  contaminating  cells,  we  labeled  highly  purified  tonsil 
CD56CD127+ cells with CFSE and stimulated with IL-2, 
IL-7, or IL-15. These cytokines were all capable of maintain-
ing LTi viability and proliferation ex vivo, although less pro-
liferation was observed when stimulated with IL-7 alone. In 
the absence of these cytokines the cells did not survive. After 6 d 
of culture, the great majority of the LTi cells up-regulated CD56 
(Fig. 1 C). Most importantly, CD56 was also up-regulated   
on CSFE-bright nondividing cells, which proves that the   
appearance of CD56+ cells is not the result of outgrowth. 
Additional kinetics experiments showed that this up-regulation 
is underway by day 4 of culture (unpublished data). We   
cannot completely exclude the fact that cells that did not 
up-regulate CD56 were more prone to cell death and that, 
therefore, these cells were underrepresented in our cultures. 
However, the observations that the cell viability was high 
(10–15% dead cells) in all conditions and that the cell num-
bers remained the same or increased during the cultures argue 
against selective death of CD56 cells. Our data indicate that 
CD56+ cells did not arise from a small contaminating popula-
tion of rapidly dividing CD56+ cells and, thus, this data sup-
ports a direct developmental relationship between CD127+ 
LTi-like cells and CD56+CD127+ cells.
Cultured CD56+CD127+ and CD127+LTi-like cells maintain 
high RORC expression
Immature stage 3 NK cells have been shown to develop into 
cNK cells (Freud et al., 2006). Because considerable pheno-
typic similarities exist between LTi-like cells and stage 3 iNK 
cells, we examined whether CD127+ LTi-like cells can convert 
into cNK cells. Using a rigorous sorting strategy, we isolated 
CD56+CD117 cNK cells, LinCD56+CD117+CD127+ cells, 
and LinCD56CD117+CD127+ LTi-like cells from human 
tonsils. The use of CD117, in conjunction with CD127 as   
selecting markers, combined with the rigorous exclusion of 
(Satoh-Takayama et al., 2008), whereas cNK cells need IL-15. 
Thus the current data suggests that LTi cells and cNK cells are 
developmentally related yet distinct lineages.
Recently, we identified a novel cell type that expresses 
RORC and CD127, as well as NK cell–associated markers 
NKp46 and CD56, but were functionally different from cNK 
cells in that they lacked expression of granzyme B and perforin, 
were noncytotoxic, and failed to produce IFN- upon activa-
tion (Cupedo et al., 2009). Rather, these CD56+ LTi-like cells 
were able to secrete IL-17 and IL-22 after activation. A cell 
type that is very similar to the CD56+CD127+ LTi cells was 
described by Cella et al. (2009) and was called NK22 because 
of the expression of NK cell markers NKp44 and CD56 and 
the production of IL-22 upon activation. Like the CD56+ LTi 
cells, NK22 cells expressed RORC, were not cytotoxic, and 
were present in human tonsils, the human intestinal lamina 
propria, and Peyer’s patches (Cella et al., 2009). In the mouse, 
cells with similar characteristics have been found in the gut. 
These cells express RORt like LTi cells, but they also express 
the NK cell marker NKp46 and are able to secrete IL-22 but   
not IFN- (Satoh-Takayama et al., 2008; Luci et al., 2009;   
Sanos et al., 2009). An outstanding question is to which lineage 
CD56+CD127+ cells belong. One possibility is that these cells 
belong to the same lineage as LTi cells, whereas another is that 
NKp46+CD56+CD127+ and cNK cells can interconvert. The 
latter possibility was suggested by the finding that human LTi 
cells are very similar to immature stage 3 NK cells, which were 
described to be precursors of cNK cells (Freud et al., 2006). 
We show in this paper that LinCD127+RORC+ LTi-like 
cells, although sharing some characteristics with cNK cells, 
represent a functionally and developmentally distinct lineage.
RESULTS AND DISCUSSION
Human CD127+ LTi-like cells are precursors of CD56+CD127+ 
cells, and have similar phenotype to NK22 cells
We have previously demonstrated that fetal LTi cells are ca-
pable of interacting with MSCs and inducing the expression   
of the adhesion molecules ICAM1 and VCAM1. We also 
found cells with a similar phenotype to that of the CD127+  
fetal lymph node cells in postnatal tonsil, but we did not test   
the LTi activity of those cells in that study (Cupedo et al., 2009). 
Fig. 1 A shows that both Lin (CD14CD19CD3TCR-
TCR-)  CD127+CD56+  and  LinCD56CD127+ 
LTi-like cells (referred to as CD127+ LTi-like cells), isolated 
from human tonsil, induced ICAM1 and VCAM1 on MSCs, 
whereas cNK cells had some ICAM-inducing capacity which 
was much lower than of CD127+ LTi-like cells and did not 
induce  VCAM1  expression.  The  observation  that  tonsil 
CD56+CD127+ cells have functional LTi activity underlines 
the functional differences between these cells and cNK cells.
It has been suggested that expression of NKp44 identifies 
a population of RORC+IL-22–producing NK cells (Cella   
et al., 2009). Fig. 1 B shows that LinCD56+CD127+ and 
CD127+ LTi-like cells in human tonsils expressed high levels 
of NKp44 and were positive for CD161, whereas cNK cells 
expressed NKp44 on only a small subset in the tonsil and were JEM VOL. 207, February 15, 2010  283
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RORC messenger RNA (mRNA), as did CD56+CD127+  
cells, whereas CD56+ cNK cells remained negative (Fig. 2 A). 
At the end of the first feeder cycle, LTi-like cell lines were 
30–60% CD56+ (Fig. 2 B). After subsequent feeder cycles, 
CD56 expression increased until 80–100% of the cells were 
CD56+. After expansion, all populations expressed similar levels 
of NKp46. CD127 was no longer detectable by flow cytom-
etry; however, LTi-like cell lines continued to express CD127 
message (Fig. S1) and to respond to IL-7 (unpublished data).   
Lin+ and/or TCR+ cells, was crucial for preventing contamina-
tion with T cells. These sorted populations were expanded ex 
vivo using a feeder mixture consisting of irradiated allogeneic   
PBMCs,  JY  EBV-transformed  lymphoblastoid  cells,  PHA,   
and IL-2, which was previously used to expand cNK cells 
(Phillips et al., 1991). Under these conditions, CD127+ LTi-
like cells expanded 30–200-fold, and after resting they could 
be successfully restimulated and further expanded. Impor-
tantly, expanded LTi-like cell lines maintained expression of 
Figure 1.  Human CD127+ LTi-like cells are precursors of CD56+CD127+ cells and have similar phenotype to NK22 cells. (A) Lin, CD56+ cNK, 
CD56+CD127+, or CD127+ LTi-like cells, were sorted from tonsil and were co-cultured with human MSCs for 4 d with 10 ng/ml IL-7. Expression of ICAM1 
and VCAM1 on MSCs was quantified by flow cytometry. (B) Expression of the indicated molecules was quantified using flow cytometry on Lin tonsil 
cells. (C) Flow cytometry–sorted CD127+ LTi cells were labeled with CFSE and stimulated with IL-7, IL-2, or IL-15 for 6 d, followed by flow cytometry to 
assess CD56 expression. One donor out of at least two analyzed is shown in A, B, and C.284 Human LTi-like cells: a stable IL-22+ lineage | Crellin et al.
cells were purified and cloned by limiting dilution at one and 
three  cells  per  well  of  a  96-well  round-bottomed  plate.   
Approximately 8–10% of the wells seeded with one cell per 
well showed robust expansion and 10–20 clones from each 
donor were characterized further. All clones expressed high 
amounts of transcripts of RORC and AHR (Fig. 2 C), a 
transcription factor which is associated with Th17 cells and 
IL-22 production (Trifari et al., 2009), and a positive correlation 
The down-regulation of CD127 is not unexpected, as it is well 
known that T cells lose CD127 expression after activation and 
expansion (Xue et al., 2002). Expanded cNK cells expressed 
CD56, but in contrast to cell lines derived from CD127+CD56 
and CD127+CD56+ cells, they lacked CD117.
To exclude potential uncertainties regarding the use of 
bulk populations, we performed a clonal analysis of CD127+ 
LTi-like cells from two donors. LinCD117+CD127+ LTi-like 
Figure 2.  Cultured CD56+CD127+ and CD127+ LTi-like cells maintain high RORC expression. Flow cytometry–sorted tonsil Lin cNK, 
CD117+CD56+CD127+, and CD117+CD127+ LTi-like cells were expanded ex vivo using a feeder cell mixture. (A) After expansion, RORC mRNA normalized  
to 18S expression. The top represents the first expansion (F1), whereas the bottom follows RORC expression in a single donor over three rounds of  
expansion. (B) Flow cytometry of the indicated molecules on expanded cell lines after one (F1) or three (F3) rounds of expansion. (C) Single cell clones of 
CD117+CD127+ LTi-like cells were generated, and RORC mRNA of clones from two donors is shown, normalized to 18S expression. Bulk cell lines from the 
same donors are shown in parallel. (D) Correlation between AHR and RORC mRNA from LTi-like cell clones. (E) Flow cytometry of the indicated molecules  
on LTi-like cell clones. Each dot in A, C, and D represents a single clone or bulk cell line. In B, a single donor representative of five is shown. In E, three 
representative clones are shown. The mean (horizontal bars) and SEM (error bars) are shown in A and C.JEM VOL. 207, February 15, 2010  285
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existed between RORC and AHR expression levels (Fig. 2 D). 
Furthermore, all clones maintained expression of CD117 and 
NKp46 and most expressed CD56, which is consistent with 
observations of expanded CD127+ LTi-like cell lines (Fig. 2 E). 
In contrast, parallel cNK cell lines were negative for CD117 
and did not express RORC.
LTi cell lines and clones maintained their ability to interact 
with MSCs and induce the expression of adhesion molecules, 
whereas cNK cell lines failed to mediate this activity (Fig. S2). 
Up-regulation of adhesion molecules could be mimicked by 
addition of exogenous TNF and lymphotoxin, and blocking 
TNF signaling through addition of TNFRII-Ig inhibited the 
up-regulation of adhesion molecules on MSCs induced by 
CD127+ LTi-like cell lines (Fig. S2). Collectively, our data 
demonstrate that LTi-like cells and their CD56+ descendants 
can be expanded ex vivo and retain their phenotypic and 
functional characteristics. Most importantly, neither the lines 
nor the clones convert into cNK cells in vitro.
Heterogeneous cytokine production from expanded  
and clonal CD127+ LTi-like cells
In vitro expanded LTi-like cells have a similar cytokine profile 
after stimulation as ex vivo cells (Fig. 3 A). Stimulation with 
PMA/ionomycin was used to reveal the intrinsic capacity of 
cells to produce cytokines. IL-22 was produced in much higher 
amounts than IL-17, suggesting that the preferential production 
Figure 3.  Heterogeneous cytokine production from expanded and clonal CD127+ LTi-like cells. (A) Cell lines were stimulated with PMA and  
ionomycin for 24 h, supernatants were collected, and cytokine production was analyzed by Luminex assays and ELISA. (B) Intracellular cytokine analysis  
of expanded cNK and CD127+LTi-like cell lines, stimulated for 6 h with PMA and ionomycin. (C and D) Intracellular cytokine analysis of LTi cell clones, 
stimulated for 6 h with PMA and ionomycin. In A, the mean value of three donors is plotted. B shows a single donor representative of at least three  
donors. In C, each dot represents a separate clone, with two donors shown. In D, three representative clones are shown from each donor. Error bars in  
A and C show SEM. Horizontal bars in C show means.286 Human LTi-like cells: a stable IL-22+ lineage | Crellin et al.
between CD56 expression and cytokine production profile. 
Over time, clones largely maintained their phenotype, although 
with in vitro culture an increase in IL-17 production was 
sometimes observed (Fig. S3).
It has been suggested that the capacity to produce IL-17 
distinguishes LTi cells from NK22 cells (Colonna, 2009). How-
ever, our analysis suggests the presence of cells that can produce 
both IL-17 and IL-22, and even IL-17 only, within the 
CD127+RORC+ population which are also NKp44+ ex vivo.
After expansion, LTi-like cell lines have low cytotoxic activity
We,  and  others,  have  documented  that  freshly  isolated   
LTi-like cells from the tonsil, like their fetal counterparts, are 
negative for granzyme and perforin (Cella et al., 2009; Cupedo 
et al., 2009; Sanos et al., 2009). Because CD56+ LTi-like cell 
lines were capable of producing IFN- (Fig. 3), we assessed 
whether they acquired cytotoxic activity. After expansion, 
LTi-like cell lines and clones expressed perforin, but at much 
lower levels compared with cNK cell lines, and did not acquire 
expression of killer cell immunoglobulin-like receptors (KIRs; 
Fig. 4, A and B; and not depicted). In contrast to LTi-like cell 
clones, LTi-like cell lines did express some granzyme B but at 
much lower than cNK cell lines (Fig. 4, A and B). In a cytotoxic 
assay with K562 cells as targets, cultured LTi-like cells achieved 
50% lysis at an effector/target ratio of 19:1, which is 13-fold 
higher than that required for cNK cell lines (Fig. 4 C), suggest-
ing that in vitro–cultured LTi-like cells acquired a moderate 
of IL-22 that was noted in freshly isolated cells was maintained 
through in vitro activation and expansion. After expansion, 
LTi-like cell lines produced amounts of IL-22 that were similar 
to those of the CD56+CD127+ cell lines upon activation, which 
is in contrast to the lower amounts produced by freshly isolated 
CD127+ LTi-like cells (Fig. 3 A; Cupedo et al., 2009). How-
ever, in contrast to fresh LTi cells, both CD56+CD127+ and 
LTi-like cell lines produced IFN- after expansion (Fig. 3 A).   
The IFN-–producing cells within the LTi cell lines may rep-
resent differentiated cNK cells that had lost the capacity to pro-
duce IL-22. However, the observation that activated IFN-– 
producing LTi cell lines were also positive for IL-22, TNF, and 
IL-17 (Fig. 3 B) argues against this possibility.
The cytokine production profile of LTi-like cell clones 
was similar to that of LTi cell lines (Fig. 3 C). Like the LTi 
lines, the clones acquired the capacity to produce IFN-. 
There was no inverse correlation between IFN- production 
and RORC mRNA in the clones (unpublished data), indicat-
ing that IFN- production was not associated with a decrease 
of expression of RORC. Clones derived from donor 1 had 
higher IL-17 production after stimulation than did clones   
derived from donor 2. Although most clones produced both 
IL-17  and  IL-22  after  stimulation,  some  clones  produced   
IL-22 but not IL-17, whereas other clones produced IL-17 
but  not  IL-22  (Fig.  3  D).  These  data  indicate  that  some   
heterogeneity, with respect to IL-22 and IL-17 production, 
exists within RORC+ LTi cell clones. There was no correlation 
Figure 4.  After ex vivo expansion, LTi cell lines have low cytotoxic activity. (A) Flow cytometry was performed for intracellular perforin, granzyme 
B, and cell surface KIR expression on cNK cell lines and CD127+ LTi-like cell lines expanded ex vivo. (B) Geometric mean fluorescence intensity of intracel-
lular granzyme B or perforin staining is shown for cNK or CD127+ LTi-like cell lines and LTi-like clones after ex vivo expansion. (C) K562 cells were labeled 
with a fluorescent dye and co-cultured with cNK or CD127+ LTi-like cell lines or LTi-like clones at the indicated ratios for 5 h, and cytotoxicity was deter-
mined by propidium iodide staining. Unlabeled K562 cells were added at the indicated ratios to assess nonspecific cell death (control). One of four donors 
analyzed is shown in A. Each dot represents a separate donor or clone in B. The mean of cell lines from two donors and three clones from a single donor 
are shown in C. Horizontal bars in B show the means. Error bars in B and C show SEM.JEM VOL. 207, February 15, 2010  287
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cells, in that they expressed CD117 and CD161, and part of 
the cells expressed CD25 (Freud et al., 2005, 2006), raising the 
possibility that some of those in vitro–generated “NK” cells are 
in fact LTi-like cells. Indeed, recently the same group reported 
that the stage 3 iNK cells, which were hypothesized to be 
downstream of CD34dimCD45RA+ precursor cells, produced 
IL-22, suggesting that at least part of these iNK are identical to 
LTi-like cells (Hughes et al., 2009). Given that CD127+CD117+ 
cells cannot differentiate into cNK, the cNK precursor within 
the CD161+CD117+ iNK population described by Freud et al. 
(2006) should be negative for CD127. To test this hypothesis, 
we purified CD127 positive and negative cells from the 
cytolytic activity. However, this activity was much lower than 
that of cNK cells. The clones derived from LTi-like cells did 
not display any cytotoxicity in this assay. Collectively, our 
data support the notion that LTi and their CD127+CD56+ 
progeny represent a lineage whose developmental pathway is 
distinct from cNK cells.
CD117+CD161+CD127 iNK cells contain cNK precursors
It has been reported that circulating CD34+CD45RA+ cells 
that are also resident in the lymph node can differentiate   
into NK cells (Freud et al., 2005). Close inspection of those in   
vitro–generated NK cells reveals some similarities with LTi-like 
Figure 5.  CD117+CD161+CD127- iNK cells contain cNK precursors. (A) LinCD117+CD161+CD127 and CD117+CD161+CD127+ cells were sorted 
from human tonsils. (B) Isolated populations were expanded ex vivo, and expression of indicated molecules was assessed by flow cytometry. (C) RORC,  
IL-22, and IFN- mRNA after ex vivo expansion, normalized to 18S expression. A single donor representative of two is shown in A and B, and C represents 
the mean and SEM of at least two donors.288 Human LTi-like cells: a stable IL-22+ lineage | Crellin et al.
cells, as indicated by our clonal analysis. In the intestinal lamina 
propria only IL-22–producing cells may be present, but is very 
well possible that similar cells producing IL-17 rather than IL-22 
are prevalent in other mucosal sites such as the lung. We have 
also found that LTi cells and CD56+RORC+ cells are able to 
produce IL-5 and IL-13 (unpublished data) and RORC+ cells 
might exist in certain tissues that are dedicated to producing 
these cytokines rather than IL-17 and/or IL-22. Such cells may 
function in the innate immune response against parasites.
MATERIALS AND METHODS
Cell purification and sorting. Human tonsils were digested for 30 min   
in 0.5 mg/ml collagenase IV (Invitrogen) at 37°C and processed to form a 
single  cell  suspension.  CD3+  and  CD19+  cells  were  depleted  using  kits 
(STEMCELL Technologies Inc.). For flow cytometry sorting, cells were   
labeled with PE-conjugated anti-CD127 (BD), PE-Cy7–conjugated anti-CD56 
(BD), APC-conjugated anti-CD117 (eBioscience), Pacific blue–conjugated 
anti-CD19  (eBioscience),  and  FITC-conjugated  anti-CD3,  TCR-, 
TCR-, and CD14 (eBioscience) antibodies. In some conditions, PE-Cy5–
conjugated anti-CD161 (BD) was also used. Cells were sorted on a FACSAria 
(BD) to >95% purity. Tonsils were obtained from Bio Options, and blood 
samples were obtained from the Genentech blood donors program after 
written informed consent. Ethical approval for the use of this material was 
obtained from the Western Institutional Review Board.
MSC assay. Human MSCs (Thermo Fisher Scientific) were cultured according 
to the supplier’s instructions. MSCs were plated in a 48-well plate at a density   
of 5 × 104 cells per well. LTi-like or cNK cells were added at a 1:1 ratio and   
co-cultured for 4 d in the presence of 10 ng/ml IL-7. ICAM1 and VCAM1   
expression on MSC was determined by flow cytometry. Where indicated,   
10 ng/ml TNF or 100 ng/ml LT12 were added at the start of culture. 100 ng/
ml TNFRII-Ig was used to block TNF signaling and was added on days 0 and 2.
Expansion of LTi cell lines and LTi-like cell clones. Flow cytometry–
sorted cells were stimulated with irradiated allogeneic PBMCs (5,000 rad) 
and irradiated JY EBV-transformed B cells (7,500 rad) in the presence of   
1 µg/ml PHA (Roche) and 100 U/ml IL-2 (Novartis). IL-2 was replenished 
every 3 d. LTi-like cell clones were generated using limited cell dilution and 
expanded using the same method.
Cell culture. Cells were cultured in Yssel’s medium (Gemini Bio-Products; 
or in house prepared) plus 1% human AB serum (Gemini Bio-Products). 
Recombinant  human  IL-7  and  IL-15  were  used  at  10  ng/ml  (R&D   
Systems). For cytokine production, 5 × 105 cells per well were plated in a 
200-µl volume in 96-well round-bottom plates.
Cytotoxic activity assay. K562 cells were labeled with a fluorescent dye 
using the Live/Dead cell–mediated cytotoxicity kit (Invitrogen) and co-
cultured with effector cell lines at the ratios indicated for 5 h. Cytotoxicity 
was determined by propidium iodide staining using flow cytometry.
Quantitative  real-time  PCR.  Total  RNA  was  extracted  using  either   
the RNeasy mini or micro kit (QIAGEN) according to the manufacturer’s 
instructions. Complementary DNA was reverse transcribed using the high-
capacity complementary DNA archive kit (Applied Biosystems). Primers and 
probes were all predesigned Taqman Gene Expression Assays from Applied 
Biosystems. Real-time PCR was performed on the 7500 Real Time System 
(Applied Biosystems) machine. The following assays were used: RORC 
(Hs01076112),  AHR  (Hs00169233),  18S  (Hs99999901),  and  IL-22 
(Hs00220924). All samples were normalized using 18S expression level and 
expressed in arbitrary units.
Flow  cytometry  and  intracellular  cytokine  staining.  Cell  surface   
staining was performed using Alexa Fluor 647–conjugated anti-NKp46 or   
LinCD161+CD117+ population and expanded them in vitro 
(Fig. 5 A). Fig. 5 B shows that, as expected, CD127+CD117+ 
cells maintain the expression of CD117 and had low levels   
of perforin and granzyme B. In contrast, the expanded 
CD127CD117+ cells lost CD117, were positive for gran-
zyme B and perforin, and had some KIR expression (Fig. 5 B). 
Both  populations  expressed  NKp46,  NKG2D,  and  CD56. 
Consistent with the cell surface phenotype, RORC and IL-22 
mRNAs were highly expressed in expanded CD117+CD127+ 
cells, expressed at low levels in CD117+CD127 cells, and not 
expressed in cNK cell lines (Fig. 5 C). In contrast, IFN- 
mRNA was expressed in all populations but most highly   
expressed in expanded cNK cells, whereas CD117+CD127 cells 
had an intermediate expression (Fig. 5 C). These data indicate 
that CD127 cNK precursors are found within the iNK cell 
population. Our data strongly suggest that iNK cells, as defined 
by Freud et al. (2006) and Hughes et al. (2009), may contain a 
mixture of LTi cells and immature cNK cells and do not nec-
essarily contain common NK/LTi cell precursors. If such a 
precursor exists, it might be present in the CD34+CD45RA± 
population (Freud et al., 2005, 2006).
The conclusion that cNK and RORC+ CD127+ LTi-like 
cells belong to different lineages is consistent with an accom-
panying paper (see Satoh-Takayama et al. in this issue). These 
researchers  found  that  development  of  NKp46+RORC+  
IL-22–producing cells, like that of LTi cells, requires IL-7 and   
is  IL-15  independent.  By  using  cell  fate  mapping,  these   
researchers also observed that cNK cells never express RORC 
during their development. Because it is very likely that mouse 
NKp46+RORC+ cells, which also express CD127, are the 
mouse homologue of the human CD56+CD127+RORC+ 
cells described in this paper, the data of this group are in 
agreement with our conclusion that human CD127+RORC+ 
cells are unable to differentiate into cNK cells. Nonetheless, 
CD127+ LTi-like cells and their CD56+ descendants seem to 
be related to cNK cells because apart from the fact that these 
cell types share expression of certain markers, development 
of both lineages in the mouse can be blocked by E2A   
proteins (Boos et al., 2007) and consequently requires the E 
protein inhibiting factor Id2. These two lineages may serve 
comparable functions in the immune response. It is well   
established that cNK cells are necessary for the initial defense 
against viruses (Lee et al., 2007). It is possible that LTi-like 
cells and their RORC+ progeny are involved in the innate 
immune response against extracellular bacteria, much like   
the IL-22 and IL-17–producing T cells, which also express 
RORC and are instrumental in the adaptive immune response 
against bacteria (Aujla et al., 2008; Ishigame et al., 2009; 
Martin et al., 2009). Indeed, we have observed that LTi cells 
express toll-like receptors and are capable of responding to 
TLR  stimulation  (unpublished  data).  Non–T  cell–derived 
IL-22 is required for protection from Citrobacter Rodentium 
infection in the intestine (Zheng et al., 2008), and IL-22–
producing RORC+ cells contribute to this response (Satoh-
Takayama et al., 2008; Cella et al., 2009). The RORC+ 
innate lymphocytes may constitute a heterogeneous group of JEM VOL. 207, February 15, 2010  289
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-NKp44,  Pe-Cy7–conjugated  anti-CD25,  and  FITC-conjugated  anti-
CD62L (all obtained from BD). KIRs were detected using FITC-conjugated 
anti-KIR2DL2 or -KIR3DL1 (BioLegend). Cells were fixed and permeabilized 
as described later in this section and stained with PE-conjugated anti–granzyme 
B and FITC-conjugated anti-perforin (eBioscience). Intracellular staining 
was performed on ex vivo expanded cell lines and clones stimulated for 6 h 
with 10 ng/ml PMA and 500 nM ionomycin (EMD) in the presence of   
5 µg/ml BFA (BD) for the final 4 h of culture. Cells were stained with LIVE/
DEAD (violet) viability assay (Invitrogen) and then fixed in 3% paraformal-
dehyde in PBS. Cell permeabilization, staining, and subsequent washings 
were performed using the Fix/perm wash buffer (eBioscience). The following 
antibodies were used (BD): PECY7-conjugated anti–IFN-, and PE-Cy7–
conjugated anti-TNF. PE-conjugated anti–IL-17A (eBioscience) and Alexa 
Fluor 647–conjugated anti–IL-22 (prepared in house) were also used. Data 
were acquired on an LSRII (BD) and analyzed with FlowJo software (Tree 
Star, Inc.). Monoclonal mouse anti–human IL-22 antibodies were generated 
in house by immunizing mice with human IL-22Fc fusion protein. Clone 3F11 
was chosen based on its ability to detect intracellular human IL-22 (Trifari et al.,   
2009). The antibody was then conjugated with Alexa Fluor 647 fluorochrome 
using a Labeling kit (Invitrogen) according to the manufacturer’s instruc-
tions. During analysis, dead cells were eliminated using the live/dead violet 
dye and doublets were eliminated based on light scattering parameters.
Luminex and ELISA. Supernatants were collected, and IL-17A, IFN-, 
and TNF were measured by Bioplex bead-based assays (Bio-Rad Laboratories) 
and read by a Luminex System (Luminex). IL-22 was measured by ELISA 
(R&D Systems) according to the manufacturer’s protocol.
Online supplemental material. Fig. S1 shows CD127 mRNA expression 
on expanded cell lines. Fig. S2 shows up-regulation of adhesion molecules   
on MSCs induced by expanded LTi-like cell lines and clones. Fig. S3   
follows cytokine production of individual clones over successive expansions in 
vitro. Online supplemental material is available at http://www.jem.org/cgi/ 
content/full/jem.20091509/DC1.
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